"
Team:MIT/Parts
From 2014.igem.org
(Difference between revisions)
Shinjini37 (Talk | contribs) |
Shinjini37 (Talk | contribs) |
||
| Line 7: | Line 7: | ||
<td><b>Part</b></td> | <td><b>Part</b></td> | ||
<td><b>Part Number</b></td> | <td><b>Part Number</b></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--0--> | <!--0--> | ||
| Line 13: | Line 13: | ||
<td>Gantenerumab Variable Human Ig-M Heavy Chain</td> | <td>Gantenerumab Variable Human Ig-M Heavy Chain</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391000"> BBa_K1391000 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391000"> BBa_K1391000 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--1--> | <!--1--> | ||
| Line 19: | Line 19: | ||
<td>Gantenerumab Variable Human Ig-M Light Chain </td> | <td>Gantenerumab Variable Human Ig-M Light Chain </td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391001"> BBa_K1391001 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391001"> BBa_K1391001 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--2--> | <!--2--> | ||
| Line 25: | Line 25: | ||
<td>CD79A</td> | <td>CD79A</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391002"> BBa_K1391002 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391002"> BBa_K1391002 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--3--> | <!--3--> | ||
| Line 31: | Line 31: | ||
<td>CD79B</td> | <td>CD79B</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391003"> BBa_K1391003 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391003"> BBa_K1391003 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--4--> | <!--4--> | ||
| Line 37: | Line 37: | ||
<td>CD79A-TCS-Gal4VP16</td> | <td>CD79A-TCS-Gal4VP16</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391004"> BBa_K1391004 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391004"> BBa_K1391004 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--5--> | <!--5--> | ||
| Line 43: | Line 43: | ||
<td>CD79B-TCS-Gal4VP16</td> | <td>CD79B-TCS-Gal4VP16</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391005"> BBa_K1391005 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391005"> BBa_K1391005 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--6--> | <!--6--> | ||
| Line 49: | Line 49: | ||
<td>Syk</td> | <td>Syk</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391006"> BBa_K1391006 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391006"> BBa_K1391006 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--7--> | <!--7--> | ||
| Line 55: | Line 55: | ||
<td>Syk-TEVp</td> | <td>Syk-TEVp</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391007"> BBa_K1391007 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391007"> BBa_K1391007 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--8--> | <!--8--> | ||
| Line 61: | Line 61: | ||
<td>Lyn</td> | <td>Lyn</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391008"> BBa_K1391008 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391008"> BBa_K1391008 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--9--> | <!--9--> | ||
| Line 67: | Line 67: | ||
<td>Lyn-TEVp</td> | <td>Lyn-TEVp</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391009"> BBa_K1391009 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391009"> BBa_K1391009 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--10--> | <!--10--> | ||
| Line 73: | Line 73: | ||
<td>pENTR_PirB</td> | <td>pENTR_PirB</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391010"> BBa_K1391010 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391010"> BBa_K1391010 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--11--> | <!--11--> | ||
| Line 79: | Line 79: | ||
<td>pENTR_LilrB2</td> | <td>pENTR_LilrB2</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391011"> BBa_K1391011 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391011"> BBa_K1391011 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--12--> | <!--12--> | ||
| Line 85: | Line 85: | ||
<td>pENTR_Coflin (Inactivated - pseudophosphorylated)</td> | <td>pENTR_Coflin (Inactivated - pseudophosphorylated)</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391012"> BBa_K1391012 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391012"> BBa_K1391012 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--13--> | <!--13--> | ||
| Line 91: | Line 91: | ||
<td>pENTR_PirB_TCS_Gal4VP16</td> | <td>pENTR_PirB_TCS_Gal4VP16</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391013"> BBa_K1391013 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391013"> BBa_K1391013 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--14--> | <!--14--> | ||
| Line 97: | Line 97: | ||
<td>pENTR_LilrB2_TCS_Gal4VP16</td> | <td>pENTR_LilrB2_TCS_Gal4VP16</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391014"> BBa_K1391014 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391014"> BBa_K1391014 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
<!--15--> | <!--15--> | ||
| Line 103: | Line 103: | ||
<td>pENTR_Cofilin(inactivated)_TEVp</td> | <td>pENTR_Cofilin(inactivated)_TEVp</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_K1391015"> BBa_K1391015 </a></td> | <td><a href="http://parts.igem.org/Part:BBa_K1391015"> BBa_K1391015 </a></td> | ||
| - | + | ||
</tr> | </tr> | ||
Revision as of 06:42, 17 October 2014
| Home |  Our Project
|
Lab Work
|
Outreach
|
About Us
|
Medals |
| Part | Part Number |
| Gantenerumab Variable Human Ig-M Heavy Chain | BBa_K1391000 |
| Gantenerumab Variable Human Ig-M Light Chain | BBa_K1391001 |
| CD79A | BBa_K1391002 |
| CD79B | BBa_K1391003 |
| CD79A-TCS-Gal4VP16 | BBa_K1391004 |
| CD79B-TCS-Gal4VP16 | BBa_K1391005 |
| Syk | BBa_K1391006 |
| Syk-TEVp | BBa_K1391007 |
| Lyn | BBa_K1391008 |
| Lyn-TEVp | BBa_K1391009 |
| pENTR_PirB | BBa_K1391010 |
| pENTR_LilrB2 | BBa_K1391011 |
| pENTR_Coflin (Inactivated - pseudophosphorylated) | BBa_K1391012 |
| pENTR_PirB_TCS_Gal4VP16 | BBa_K1391013 |
| pENTR_LilrB2_TCS_Gal4VP16 | BBa_K1391014 |
| pENTR_Cofilin(inactivated)_TEVp | BBa_K1391015 |
